• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MOLES 和 TFSOM-DIM 评分在脉络膜痣和黑色素瘤分类中的表现。

Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma.

机构信息

Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Department of Ophthalmology, University of Bonn, Bonn, Germany.

出版信息

Sci Rep. 2024 Nov 18;14(1):28534. doi: 10.1038/s41598-024-78692-w.

DOI:10.1038/s41598-024-78692-w
PMID:39557904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11574176/
Abstract

Choroidal nevi are common benign melanocytic lesions often incidentally found during routine ophthalmic examinations. Patients with choroidal nevi are frequently referred to ocular oncology centers to differentiate these from choroidal melanoma and to exclude a malignant transformation which rarely occurs. However, this causes a high workload for referral centers and may delay diagnosis and treatment of patients with potentially severe conditions. To overcome this, the MOLES score was previously developed which may empower non-specialists to differentiate choroidal nevi from melanoma. In this retrospective study, the performance of the MOLES score was assessed in 695 patients with choroidal nevi and 53 with choroidal melanoma. With a specificity of 96% (choroidal nevi) and a sensitivity of 100% (melanoma) the MOLES score was highly successful in differentiating choroidal nevi from melanoma and may offer great potential to optimize monitoring and referral decisions, and for teleophthalmology applications. Furthermore, the TFSOM-DIM score using risk factors for determining tumor progression was applied and showed a good correlation with MOLES. A complementary use of MOLES and TFSOM-DIM may be beneficial for clinical routine: MOLES for screening by non-experts with limited diagnostic tools and TFSOM-DIM in a referral setting to counsel also regarding potential transformation.

摘要

脉络膜痣是常见的良性黑色素细胞病变,常在眼科常规检查中偶然发现。脉络膜痣患者常被转诊至眼肿瘤科,以将其与脉络膜黑色素瘤区分开来,并排除罕见的恶变。然而,这给转诊中心带来了很大的工作量,并可能延误对有潜在严重情况的患者的诊断和治疗。为了克服这一问题,之前开发了 MOLES 评分,它可以使非专家能够区分脉络膜痣和黑色素瘤。在这项回顾性研究中,评估了 MOLES 评分在 695 例脉络膜痣和 53 例脉络膜黑色素瘤患者中的表现。MOLES 评分具有 96%(脉络膜痣)的特异性和 100%(黑色素瘤)的敏感性,成功地将脉络膜痣与黑色素瘤区分开来,可能为优化监测和转诊决策以及远程眼科应用提供巨大潜力。此外,还应用了 TFSOM-DIM 评分,使用肿瘤进展的危险因素来判断肿瘤,结果显示与 MOLES 具有良好的相关性。MOLES 和 TFSOM-DIM 的互补使用可能有益于临床常规:MOLES 可用于非专家使用有限的诊断工具进行筛查,而 TFSOM-DIM 则可用于转诊,以评估潜在的恶变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/089fb9e22ee0/41598_2024_78692_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/8679d6c21f54/41598_2024_78692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/eae6a084dd0a/41598_2024_78692_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/089fb9e22ee0/41598_2024_78692_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/8679d6c21f54/41598_2024_78692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/eae6a084dd0a/41598_2024_78692_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3669/11574176/089fb9e22ee0/41598_2024_78692_Fig3_HTML.jpg

相似文献

1
Performance of the MOLES and TFSOM-DIM scores in classifying choroidal nevi and melanoma.MOLES 和 TFSOM-DIM 评分在脉络膜痣和黑色素瘤分类中的表现。
Sci Rep. 2024 Nov 18;14(1):28534. doi: 10.1038/s41598-024-78692-w.
2
Real-world experience of implementing the MOLES score in a virtual choroidal naevi clinic at a tertiary referral centre.在一家三级转诊中心的虚拟脉络膜痣诊所实施 MOLES 评分的真实世界经验。
Eye (Lond). 2024 Apr;38(6):1183-1188. doi: 10.1038/s41433-023-02864-7. Epub 2023 Dec 6.
3
Choroidal Nevus Features Associated with Subspecialty Referral.脉络膜痣的特征与专科转诊相关。
Ophthalmol Retina. 2023 Dec;7(12):1097-1108. doi: 10.1016/j.oret.2023.07.022. Epub 2023 Jul 29.
4
CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture.3806 例脉络膜痣的影像学特征及 2355 例恶变危险因素:2020 年泰勒·R·史密斯和维克多·T·柯廷讲座。
Retina. 2019 Oct;39(10):1840-1851. doi: 10.1097/IAE.0000000000002440.
5
Optical coherence tomography in diagnosing, differentiating and monitoring of choroidal nevi - 1 year observational study.光学相干断层扫描在脉络膜痣诊断、鉴别及监测中的应用——1年观察性研究
Neuro Endocrinol Lett. 2013;34(6):539-42.
6
The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?MOLES 系统指导黑素细胞性脉络膜肿瘤的管理:视光师可以应用它吗?
Clin Exp Optom. 2023 Apr;106(3):271-275. doi: 10.1080/08164622.2022.2029685. Epub 2022 Feb 13.
7
Fundus autofluorescence of choroidal nevus and melanoma.脉络膜痣和黑色素瘤的眼底自发荧光
Br J Ophthalmol. 2007 Oct;91(10):1299-302. doi: 10.1136/bjo.2007.116665. Epub 2007 Apr 12.
8
Understanding choroidal nevus risk factors for transformation into melanoma.了解脉络膜痣转化为黑色素瘤的风险因素。
Clin Dermatol. 2024 Jan-Feb;42(1):38-45. doi: 10.1016/j.clindermatol.2023.10.012. Epub 2023 Oct 20.
9
Digital imaging in differential diagnosis of small choroidal melanoma.数字成像在小脉络膜黑色素瘤鉴别诊断中的应用
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1581-90. doi: 10.1007/s00417-005-0202-5.
10
Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.使用MOLES算法区分脉络膜痣与黑色素瘤:在眼部痣诊所的评估
Ocul Oncol Pathol. 2021 Sep;7(4):294-302. doi: 10.1159/000511363. Epub 2021 Mar 15.

本文引用的文献

1
Real-world experience of implementing the MOLES score in a virtual choroidal naevi clinic at a tertiary referral centre.在一家三级转诊中心的虚拟脉络膜痣诊所实施 MOLES 评分的真实世界经验。
Eye (Lond). 2024 Apr;38(6):1183-1188. doi: 10.1038/s41433-023-02864-7. Epub 2023 Dec 6.
2
Multimodal imaging risk factors predictive of small choroidal melanocytic lesion growth to melanoma: An educational study and pictorial guide.预测小脉络膜黑素细胞病变发展为黑色素瘤的多模态成像危险因素:一项教育性研究及图片指南
Eye (Lond). 2024 Mar;38(4):798-805. doi: 10.1038/s41433-023-02782-8. Epub 2023 Oct 25.
3
Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours?
MOLES 缩写和评分系统能否改善脉络膜黑素瘤患者的管理?
Eye (Lond). 2023 Apr;37(5):830-836. doi: 10.1038/s41433-022-02143-x. Epub 2022 Jun 28.
4
[Sustainability in ophthalmology : Adaptation to the climate crisis and mitigation].[眼科领域的可持续发展:适应气候危机与缓解措施]
Ophthalmologie. 2022 Jun;119(6):567-576. doi: 10.1007/s00347-022-01608-4. Epub 2022 Apr 22.
5
The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?MOLES 系统指导黑素细胞性脉络膜肿瘤的管理:视光师可以应用它吗?
Clin Exp Optom. 2023 Apr;106(3):271-275. doi: 10.1080/08164622.2022.2029685. Epub 2022 Feb 13.
6
Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.使用MOLES算法区分脉络膜痣与黑色素瘤:在眼部痣诊所的评估
Ocul Oncol Pathol. 2021 Sep;7(4):294-302. doi: 10.1159/000511363. Epub 2021 Mar 15.
7
What's in a Name? Large Choroidal Nevus, Small Choroidal Melanoma, or Indeterminate Melanocytic Tumor.名字意味着什么?大脉络膜痣、小脉络膜黑色素瘤还是不确定的黑素细胞肿瘤。
Ocul Oncol Pathol. 2021 Sep;7(4):235-238. doi: 10.1159/000516536. Epub 2021 Jun 7.
8
Diagnosis of Inherited Retinal Diseases.遗传性视网膜疾病的诊断。
Klin Monbl Augenheilkd. 2021 Mar;238(3):249-259. doi: 10.1055/a-1388-7236. Epub 2021 Mar 30.
9
Prospective validation of a virtual clinic pathway in the management of choroidal naevi: the NAEVUS study Report no. 1: safety assessment.脉络膜痣管理中虚拟诊所路径的前瞻性验证:NAEVUS研究报告第1号:安全性评估
Br J Ophthalmol. 2022 Jan;106(1):128-134. doi: 10.1136/bjophthalmol-2020-317371. Epub 2020 Oct 9.
10
Detecting Progression of Melanocytic Choroidal Tumors by Sequential Imaging: Is Ultrasonography Necessary?通过序列成像检测脉络膜黑素细胞肿瘤的进展:超声检查是否必要?
Cancers (Basel). 2020 Jul 10;12(7):1856. doi: 10.3390/cancers12071856.